Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076.SS)
CNY 49.04
(-1.9%)
CNY 49.04
(-1.9%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 162.93 Million CNY | 26.2% |
| 2022 | 129.1 Million CNY | 11.89% |
| 2021 | 115.38 Million CNY | -6.52% |
| 2020 | 123.44 Million CNY | 153.94% |
| 2019 | 48.61 Million CNY | 10.71% |
| 2018 | 43.9 Million CNY | 4.72% |
| 2017 | 41.92 Million CNY | 156.06% |
| 2016 | -74.79 Million CNY | -148.05% |
| 2015 | -30.15 Million CNY | -19.86% |
| 2014 | -25.15 Million CNY | -84.49% |
| 2013 | -13.63 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 66.32 Million CNY | -6.87% |
| 2024 Q3 | 123.08 Million CNY | -23.47% |
| 2024 Q2 | 160.83 Million CNY | 142.49% |
| 2023 Q4 | 71.22 Million CNY | 42.85% |
| 2023 FY | 162.93 Million CNY | 26.2% |
| 2023 Q1 | 21.01 Million CNY | -72.32% |
| 2023 Q2 | 20.83 Million CNY | -0.83% |
| 2023 Q3 | 49.86 Million CNY | 139.26% |
| 2022 Q4 | 75.91 Million CNY | 313.43% |
| 2022 FY | 129.1 Million CNY | 11.89% |
| 2022 Q2 | 18.74 Million CNY | 16.45% |
| 2022 Q1 | 16.09 Million CNY | -61.78% |
| 2022 Q3 | 18.36 Million CNY | -2.02% |
| 2021 FY | 115.38 Million CNY | -6.52% |
| 2021 Q4 | 42.1 Million CNY | 92.58% |
| 2021 Q2 | 11.72 Million CNY | -70.45% |
| 2021 Q3 | 21.86 Million CNY | 86.43% |
| 2021 Q1 | 39.68 Million CNY | 0.36% |
| 2020 Q1 | 3.96 Million CNY | -61.12% |
| 2020 Q4 | 39.54 Million CNY | 11.38% |
| 2020 FY | 123.44 Million CNY | 153.94% |
| 2020 Q2 | 44.42 Million CNY | 1020.83% |
| 2020 Q3 | 35.5 Million CNY | -20.07% |
| 2019 Q3 | 15.44 Million CNY | -5.39% |
| 2019 FY | 48.61 Million CNY | 10.71% |
| 2019 Q4 | 10.19 Million CNY | -34.0% |
| 2019 Q2 | 16.32 Million CNY | 144.46% |
| 2019 Q1 | 6.67 Million CNY | 278.83% |
| 2018 Q4 | 1.76 Million CNY | -72.75% |
| 2018 FY | 43.9 Million CNY | 4.72% |
| 2018 Q1 | -1.18 Million CNY | -105.0% |
| 2018 Q2 | 36.86 Million CNY | 3208.48% |
| 2018 Q3 | 6.46 Million CNY | -82.45% |
| 2017 Q3 | 11.41 Million CNY | -4.31% |
| 2017 FY | 41.92 Million CNY | 156.06% |
| 2017 Q1 | -2.32 Million CNY | 91.66% |
| 2017 Q4 | 23.69 Million CNY | 107.51% |
| 2017 Q2 | 11.93 Million CNY | 613.49% |
| 2016 Q2 | -8.46 Million CNY | 0.0% |
| 2016 Q4 | -27.85 Million CNY | 0.0% |
| 2016 Q3 | -27.85 Million CNY | -228.99% |
| 2016 Q1 | -8.46 Million CNY | -3.81% |
| 2016 FY | -74.79 Million CNY | -148.05% |
| 2015 Q1 | -6.92 Million CNY | 0.0% |
| 2015 Q2 | -6.92 Million CNY | 0.0% |
| 2015 Q4 | -8.15 Million CNY | 0.0% |
| 2015 FY | -30.15 Million CNY | -19.86% |
| 2015 Q3 | -8.15 Million CNY | -17.84% |
| 2014 FY | -25.15 Million CNY | -84.49% |
| 2013 FY | -13.63 Million CNY | 0.0% |